Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02607774
What this trial is testing

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT05547490
What this trial is testing

Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 3,506
Testing effectiveness (Phase 2)Study completedNCT00151008
What this trial is testing

Bexarotene With Narrow-Band UVB for Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 35
Post-approval studies (Phase 4)Study completedNCT00881868
What this trial is testing

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Scalp Psoriasis
Galderma R&D 81
Not applicableStudy completedNCT05102474
What this trial is testing

Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis Vulgaris
University of California, San Francisco 24
Large-scale testing (Phase 3)Study completedNCT06066125
What this trial is testing

Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 351
Post-approval studies (Phase 4)Study completedNCT03441789
What this trial is testing

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
L.H. Kircik, M.D. 28
Testing effectiveness (Phase 2)Study completedNCT06602219
What this trial is testing

LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 222
Testing effectiveness (Phase 2)Ended earlyNCT01704599
What this trial is testing

Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Wayne State University 8
Testing effectiveness (Phase 2)UnknownNCT06077331
What this trial is testing

Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 120
Testing effectiveness (Phase 2)Study completedNCT03392311
What this trial is testing

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 8
Large-scale testing (Phase 3)Ended earlyNCT02786732
What this trial is testing

Study to Evaluate Broadlumab vs Placebo and Ustekinumab

Who this might be right for
Psoriasis
MedDerm Associates 15
Testing effectiveness (Phase 2)Study completedNCT00399906
What this trial is testing

BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 99
Large-scale testing (Phase 3)Study completedNCT01550744
What this trial is testing

Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Biotech, Inc. 478
Testing effectiveness (Phase 2)Study completedNCT03463187
What this trial is testing

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 211
Very early researchStudy completedNCT05282771
What this trial is testing

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 402
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Large-scale testing (Phase 3)Study completedNCT02445807
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Promius Pharma, LLC 265
Large-scale testing (Phase 3)Study completedNCT00111436
What this trial is testing

Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

Who this might be right for
Psoriasis
Amgen 912
Early research (Phase 1)Study completedNCT02529956
What this trial is testing

Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis

Who this might be right for
Mild to Moderate Psoriasis
UCB Celltech 39
Next Page